Is melatonin deficiency a unifying pathomechanism of high risk patients with COVID-19?
作者信息
Simko Fedor, Reiter Russel J
机构信息
Institute of Pathophysiology, Faculty of Medicine, Comenius University, Sasinkova 4, 811 08 Bratislava, Slovak Republic; Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovak Republic.
Department of Cell Systems and Anatomy, UT Health San Antonio, San Antonio, TX, USA.
出版信息
Life Sci. 2020 Sep 1;256:117902. doi: 10.1016/j.lfs.2020.117902. Epub 2020 Jun 3.
Abstract
摘要
相似文献
1
Is melatonin deficiency a unifying pathomechanism of high risk patients with COVID-19?褪黑素缺乏是新冠病毒肺炎高危患者的共同发病机制吗？
Life Sci. 2020 Sep 1;256:117902. doi: 10.1016/j.lfs.2020.117902. Epub 2020 Jun 3.
2
Delirium, sleep, COVID-19 and melatonin.谵妄、睡眠、新冠病毒与褪黑素
Sleep Med. 2020 Nov;75:542. doi: 10.1016/j.sleep.2020.05.028. Epub 2020 May 27.
3
Reply to 'Delirium, sleep, COVID-19 and melatonin'.对《谵妄、睡眠、新冠病毒病与褪黑素》的回复
Sleep Med. 2020 Nov;75:543. doi: 10.1016/j.sleep.2020.05.027. Epub 2020 May 25.
4
Correspondence COVID-19: Melatonin as a potential adjuvant treatment.通信：新型冠状病毒肺炎（COVID-19）：褪黑素作为一种潜在的辅助治疗方法
Life Sci. 2020 Jul 15;253:117716. doi: 10.1016/j.lfs.2020.117716. Epub 2020 Apr 22.
5
Comment on Melatonin as a potential adjuvant treatment for COVID-19.关于褪黑素作为新冠病毒病潜在辅助治疗方法的评论。
Life Sci. 2020 Jul 15;253:117739. doi: 10.1016/j.lfs.2020.117739. Epub 2020 Apr 30.
6
Melatonin as a putative protection against myocardial injury in COVID-19 infection.褪黑素作为一种可能预防新型冠状病毒肺炎感染所致心肌损伤的物质。
Expert Rev Clin Pharmacol. 2020 Sep;13(9):921-924. doi: 10.1080/17512433.2020.1814141. Epub 2020 Sep 7.
7
Delirium and sleep disturbances in COVID-19: a possible role for melatonin in hospitalized patients?新型冠状病毒肺炎中的谵妄与睡眠障碍：褪黑素在住院患者中可能发挥的作用？
Sleep Med. 2020 Jun;70:111. doi: 10.1016/j.sleep.2020.04.006. Epub 2020 Apr 17.
8
A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial.一项评估褪黑素预防高危接触者 SARS-CoV-2 感染有效性的随机多中心临床试验（MeCOVID 试验）：一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):466. doi: 10.1186/s13063-020-04436-6.
9
Clinical trial to test the efficacy of melatonin in COVID-19.临床试验，旨在测试褪黑素在 COVID-19 中的疗效。
J Pineal Res. 2020 Oct;69(3):e12683. doi: 10.1111/jpi.12683. Epub 2020 Aug 8.
10
Integrative considerations during the COVID-19 pandemic.2019冠状病毒病大流行期间的综合考量
Explore (NY). 2020 Nov-Dec;16(6):354-356. doi: 10.1016/j.explore.2020.03.007. Epub 2020 Mar 26.
引用本文的文献
1
Melatonin as a Potential Approach to Anxiety Treatment.褪黑素作为一种治疗焦虑的潜在方法。
Int J Mol Sci. 2022 Dec 19;23(24):16187. doi: 10.3390/ijms232416187.
2
Melatonin: highlighting its use as a potential treatment for SARS-CoV-2 infection.褪黑素：强调其在治疗 SARS-CoV-2 感染方面的潜在用途。
Cell Mol Life Sci. 2022 Feb 20;79(3):143. doi: 10.1007/s00018-021-04102-3.
3
Mechanisms and clinical evidence to support melatonin's use in severe COVID-19 patients to lower mortality.支持褪黑素在重症 COVID-19 患者中降低死亡率的作用机制和临床证据。
Life Sci. 2022 Apr 1;294:120368. doi: 10.1016/j.lfs.2022.120368. Epub 2022 Jan 30.
4
The Reserve/Maximum Capacity of Melatonin's Synthetic Function for the Potential Dimorphism of Melatonin Production and Its Biological Significance in Mammals.褪黑素合成功能的储备/最大能力与褪黑素产生的潜在二态性及其在哺乳动物中的生物学意义。
Molecules. 2021 Dec 2;26(23):7302. doi: 10.3390/molecules26237302.
5
Phytomelatonin: a potential phytotherapeutic intervention on COVID-19-exposed individuals.植物褪黑素：一种针对 COVID-19 暴露个体的植物治疗干预措施。
Microbes Infect. 2022 Feb;24(1):104886. doi: 10.1016/j.micinf.2021.104886. Epub 2021 Sep 15.
6
What if melatonin could help patients with severe COVID-19?如果褪黑素能帮助患有严重新冠肺炎的患者会怎样？
J Clin Sleep Med. 2022 Jan 1;18(1):335-336. doi: 10.5664/jcsm.9554.
7
Melatonin for the Early Treatment of COVID-19: A Narrative Review of Current Evidence and Possible Efficacy.褪黑素治疗 COVID-19 的早期应用：对现有证据和可能疗效的叙述性综述。
Endocr Pract. 2021 Aug;27(8):850-855. doi: 10.1016/j.eprac.2021.06.001. Epub 2021 Jun 10.
8
Targeting Host Defense System and Rescuing Compromised Mitochondria to Increase Tolerance against Pathogens by Melatonin May Impact Outcome of Deadly Virus Infection Pertinent to COVID-19.通过褪黑素靶向宿主防御系统和挽救受损的线粒体来提高对病原体的耐受性可能会影响与 COVID-19 相关的致命病毒感染的结果。
Molecules. 2020 Sep 25;25(19):4410. doi: 10.3390/molecules25194410.
9
Matrix metallopeptidase 9 as a host protein target of chloroquine and melatonin for immunoregulation in COVID-19: A network-based meta-analysis.基质金属蛋白酶 9 作为氯喹和褪黑素在 COVID-19 中免疫调节的宿主蛋白靶标：基于网络的荟萃分析。
Life Sci. 2020 Sep 15;257:118096. doi: 10.1016/j.lfs.2020.118096. Epub 2020 Jul 15.
本文引用的文献
1
COVID-19: Melatonin as a potential adjuvant treatment.新型冠状病毒肺炎：褪黑素作为一种潜在的辅助治疗方法。
Life Sci. 2020 Jun 1;250:117583. doi: 10.1016/j.lfs.2020.117583. Epub 2020 Mar 23.
2
Experimental models of melatonin-deficient hypertension.褪黑素缺乏性高血压的实验模型。
Front Biosci (Landmark Ed). 2013 Jan 1;18(2):616-25. doi: 10.2741/4125.
3
Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.褪黑素与衰老和疾病——分泌减少的多种后果、治疗的选择和限制。
Aging Dis. 2012 Apr;3(2):194-225. Epub 2011 Feb 10.
4
Decreased level of melatonin in serum predicts left ventricular remodelling after acute myocardial infarction.血清褪黑素水平降低可预测急性心肌梗死后左心室重构。
J Pineal Res. 2012 Oct;53(3):319-23. doi: 10.1111/j.1600-079X.2012.01001.x. Epub 2012 Apr 27.
5
Melatonin levels decrease in type 2 diabetic patients with cardiac autonomic neuropathy.2型糖尿病合并心脏自主神经病变患者的褪黑素水平降低。
J Pineal Res. 2005 Aug;39(1):43-9. doi: 10.1111/j.1600-079X.2005.00213.x.
6
Impaired nocturnal melatonin secretion in non-dipper hypertensive patients.非勺型高血压患者夜间褪黑素分泌受损。
Blood Press. 2003;12(1):19-24.
Zotero 插件